Nicola Hanania

Feb 18, 2025 | onlinelibrary.wiley.com | Christian Domingo |William W. Busse |Nicola Hanania |Muyesser Ertugrul

1 Introduction Asthma is a common chronic respiratory disease, with a prevalence previously shown to be 5.5% [1-3]. Asthma is a heterogenous disease which may present as one of several endotypes and clinical phenotypes, based on the underlying biological mechanisms of the disease [4]. Allergic asthma is the most common asthma phenotype, it is characterized by early disease onset, immunoglobulin E (IgE) sensitisation to the causative allergen and a type 2 (T2) inflammatory response [5].

Jan 10, 2025 | digitalcommons.library.tmc.edu | Javad Razjouyan |Nicola Hanania |Sara Nowakowski |Ritwick Agrawal

BACKGROUND: Disturbed sleep in patients with COPD impact quality of life and predict adverse outcomes. RESEARCH QUESTION: To identify distinct phenotypic clusters of patients with COPD using objective sleep parameters and evaluate the associations between clusters and all-cause mortality to inform risk stratification. STUDY DESIGN AND METHODS: A longitudinal observational cohort study using nationwide Veterans Health Administration data of patients with COPD investigated for sleep disorders.

Aug 27, 2024 | journal.copdfoundation.org | Nicola Hanania

Running Head: PDE Inhibition for COPD Therapy Funding Support: Medical writing support for the development of this article was provided by Laura Weber, PhD, CMPP, from Citrus Scientific, a Citrus Health Group, Inc., company (Chicago, Illinois), and was funded by Verona Pharma plc (Raleigh, North Carolina) in accordance with Good Publication Practice (GPP 2022) guidelines.

May 20, 2024 | nejm.org | Surya P. Bhatt |Klaus F Rabe |Nicola Hanania |Claus Vogelmeier

Published May 20, 2024DOI: 10.1056/NEJMoa2401304 For permission requests, please contact NEJM Reprints at [email protected] article was published on May 20, 2024, at NEJM.org. A data sharing statement provided by the authors is available with the full text of this article at NEJM.org. Supported by Sanofi and Regeneron Pharmaceuticals. Dr. Singh is supported by the National Institute for Health Research Manchester Biomedical Research Centre.

Sep 6, 2023 | resmedjournal.com | Nicola Hanania

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.